Summary:
We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease (cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) in both skin and visceral cGVHD. The median time from transplant to initiation of ECP was 790 days. ECP was administered for 2 consecutive days every 2 weeks in 17 patients and once a week in eight patients until best response or stable disease. The median duration of therapy was 9 months (range 3–24 months). In all, 20 patients had improvement in cutaneous GVHD and six had healing of oral ulcerations. Steroid sparing or discontinuation of immunosuppressive medications was possible in 80% of patients. Response rates were similar between patients receiving treatment weekly vs every 2 weeks and in patients commencing ECP less than vs greater than 18 months from transplant (70 vs 66%). When patients were stratified based on the Akpek prognostic score, there was no difference in overall response between the favorable (Akpek score<2.5) and unfavorable risk groups, but patients with progressive onset cGVHD tended to have a higher response than those with de novo onset. In summary, we report improvement in skin and/or visceral cGVHD in 71% overall and 61% of high-risk patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrara J, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.
Tsoi MS, Storb R, Dobbs S et al. Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease. J Immunol 1980; 125: 2258–2262.
Alcindor T, Gorgun G, Miller K et al. Immunomodulatory effects of extracoroporeal photophoresis in patients with extensive chronic graft-versus-host disease. Blood 2001; 98: 1622–1625.
Vogelsang GB, Wolff D, Altomonte V et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant 1996; 17: 1061–1067.
Eppinger T, Ehninger G, Steinert M et al. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease. Transplantation 1990; 50: 807–811.
Aubin F, Brion A, Deconinck E et al. Phototherapy in the treatment of cutaneous graft-vs-host disease. Our preliminary experience in resistant patients. Transplantation 1995; 59: 151–155.
Jampel RM, Farmer ER, Vogelsang GB et al. PUVA therapy for chronic cutaneous graft-vs-host disease. Archi Dermatol 1991; 127: 1673–1678.
Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316: 297–303.
Barr ML, Meiser BM, Eisen HJ et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998; 339: 1744–1751.
Barr ML, Baker CJ, Schenkel FA et al. Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation. Clin Transplant 2000; 14: 162–166.
Barr ML . Photopheresis for the prevention and treatment of transplant rejection. J Cutan Med Surg 2003.
Costanzo-Nordin MR, Hubbell EA, O'Sullivan EJ et al. Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report. Circulation 1992; 86 (Suppl.): II242–II250.
Costanzo-Nordin MR, Hubbell EA, O'Sullivan EJ et al. Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992; 53: 808–815.
Costanzo-Nordin MR, McManus BM, Wilson JE et al. Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: a preliminary clinical and immunopathologic report. Transplant Proc 1993; 25 (Part 2): 881–883.
Dall'Amico R, Murer L, Montini G et al. Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 1998; 9: 121–127.
Dall'Amico R, Montini G, Murer L et al. Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection. Int J Artif Organs 2000; 23: 49–54.
DeNofrio D, Rosengard BR, Reynolds C et al. Rescue photochemotherapy for the treatment of acute cardiac rejection in the absence of cyclosporine maintenance therapy. J Heart Lung Transplant 1998; 17: 1036–1037.
Rook AH, Wolfe JT . Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. J Clin Apheresis 1994; 9: 28–30.
Bladon J, Taylor PC . Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 1999; 107: 707–711.
Aringer M, Granlinger WB, Smolen JS et al. Photophoresis treatment enhances CD95 (Fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol 1997; 36: 1276–1282.
Dall'Amico R, Messina C . Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apher 2002; 6: 296–304.
Gorgun G, Miller KB, Foss FM . Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002; 100: 941–947.
Foss FM, Gorgun G, Miller KB . Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 719–725.
Child FJ, Ratnavel R, Watkins P et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999; 23: 881–887.
Greinix H, Volc-Platzer B, Rabitsch W et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098–3104.
Greinix HT, Volc-Platzer B, Kalhs P et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000; 96: 2426–2431.
Peters C, Minkov M, Gadner H et al. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant 2000; 26: 405–411.
Ratanatharathorn V, Ayash L, Lazarus HM et al. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001; 28: 121–129.
Schooneman F, Claise C . Treatment of graft versus host disease (GVHD) by photopheresis? Transfus Sci 1996; 17: 527–536.
Dall'Amico R, Rossetti F, Zulian F et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997; 97: 848–854.
Knobler R . Extracorporeal photochemotherapy – present and future. Vox Sang 2000; 78 (Suppl. 2): 197–201.
Owsianowski M, Gollnick H, Siegert W et al. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994; 14: 845–848.
Rossetti F, Zulian F, Dall'Amico R et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation 1995; 59: 149–151.
Rossetti F, Dall'Amico R, Crovetti G et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996; 18 (Suppl. 2): 175–181.
Rossetti F, Zulian F, Dall'Amico R et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous chronic graft-versus-host disease. Transplantation 1995; 59: 149–151.
Rossetti F, Dall'Amico R, Crovetti G et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996; 18 (Suppl. 2): 175–181.
Russell-Jones R . Extracorporeal photophoresis in chronic cutaneous graft-versus-host disease. Bone Marrow Transplant 1998; 22: 621–623.
Apisarnthanarax N, Donato M, Korbling M et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003; 31: 459–465.
Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.
Akpek G, Zahurak ML, Piantadosi S et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219–1226.
Lim HW, Edelson RL . Photophoresis for the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin N Am 1995; 9: 1117–1126.
Wolfe JT, Lessin SR, Singh AH et al. Review of immunomodulation by photophoresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs 1994; 18: 888–897.
Shlomchik WD, Couzens MS, Gang CB et al. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415.
Chan G, Gorgun G, Miller KB, Foss FM Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 170–176.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Foss, F., DiVenuti, G., Chin, K. et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 35, 1187–1193 (2005). https://doi.org/10.1038/sj.bmt.1704984
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704984
Keywords
This article is cited by
-
Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease
Bone Marrow Transplantation (2019)
-
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
Bone Marrow Transplantation (2019)
-
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Bone Marrow Transplantation (2018)
-
Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease
International Journal of Hematology (2018)
-
Update zur extrakorporalen Photopherese
Der Hautarzt (2015)